Mutation of the ALS2 gene encoding alsin is linked to the onset of autosomal recessive motor neuron diseases, including juvenile-onset amyotrophic lateral sclerosis (ALS). Alsin long form (LF) belongs to the family of the guanine nucleotide exchanging factor (GEF) for small GTPases. Expression of alsin LF, but not alsin short form, protected motor neuronal cells from toxicity induced by mutants of the Cu/Zn-superoxide dismutase (SOD1) gene, which cause autosomal dominant ALS. In contrast, expression of alsin did not suppress neurotoxicity by other neurodegenerative insults such as Alzheimer's disease-related genes. Deletion analysis of alsin LF demonstrated that the RhoGEF domain is essential for alsin-mediated neuroprotection. Furthermore, we found that alsin LF bound to SOD1 mutants, but not to wtSOD1, via the RhoGEF domain. Such functional and physical interaction between two ALS-related genes will become a promising clue to clarify the pathogenesis of ALS and other motor neuron diseases.
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Motor neuron diseases (MNDs)
1 display selective loss of upper and/or lower motor neurons. Amyotrophic lateral sclerosis (ALS) is the most common MND and is characterized by progressive loss of both upper and lower motor neurons (see Ref. 1 for review). Primary lateral sclerosis is a rare MND with selective loss of upper motor neurons. Typical ALS occurs sporadically for middle-aged persons and is fatal within 1-5 years of the onset of the disease. In 90 -95% of instances, there is no obvious genetic linkage, but the remaining 5-10% of cases show familial inheritance. The hereditary pattern is mostly autosomal dominant, but there are rare patient groups suffering from autosomal recessive ALS.
Genetic analysis clarified that point mutations in Cu/Znsuperoxide dismutase (SOD1), a ubiquitously expressed enzyme that removes oxidative stress by scavenging superoxides, are one cause of dominantly inherited ALS (2) . Multiple groups have reported that SOD1 mutants cause death in primary neurons and neuronal cell lines (3) (4) (5) . Currently, SOD1 mutants are considered to cause ALS by gain of toxic function, and various hypotheses have been proposed regarding SOD1 mutant-mediated neurotoxicity. Expression of SOD1 mutants increased oxidative stress; the production of the reactive oxygen species is elevated by expression of SOD1 mutants (6) , and hydroxyl radical generation is elevated in G93A-SOD1 transgenic mice (7) . SOD1 mutants inhibit slow axonal transport; axonal transport is reduced in G93A-SOD1 transgenic mice (8) , and slowing axonal transport occurs as a very early manifestation of toxicity by SOD1 mutants (9) . Also, expression of SOD1 mutants causes vacuolar degeneration of mitochondria (10) and dysfunction of oxidative phosphorylation in mitochondria (11) . Furthermore, expression of SOD1 mutants results in neurotoxic aggregation, irrespective of the presence of wt-SOD1, supporting the notion that SOD1 mutants cause neurotoxicity by gain of function (12, 13) . Despite such vigorous studies, the key molecular mechanisms for SOD1 mutant-induced motor neuronal death still remain unclear.
Most recently, two groups have discovered the ALS2 gene on chromosome 2q33, which is linked to autosomal recessive ALS, from inbred families in the Middle East and North Africa (14, 15) . The protein encoded by the ALS2 gene has been named alsin (15) . The ALS2 gene has two splicing variants; the longer variant encodes alsin long form (LF) consisting of 1657 amino acids, and the shorter encodes alsin short form (SF) consisting of 396 amino acids (Fig. 1) . Although the function of alsin has been little understood, it has been noted that alsin LF has three small GTPase regulator-homologous domains as follows: the regulator of chromosome condensation 1 (RCC1) domain, the Rho guanine nucleotide exchanging factor (RhoGEF) domain, and the vacuolar protein sorting 9 (VPS9) domain, each of which is considered to act as a GTPase regulator (14) . It is noteworthy that Otomo et al. (16) found that the VPS9 domain of alsin acts as a GEF for the small GTPase Rab5 and is involved in endosomal dynamics (16) , suggesting that alsin plays a role in a certain intracellular signal transduction pathway and/or a cytoplasmic transport system. However, the functions and roles of the other domains of alsin LF remain totally unclear.
From families suffering from MNDs on the Arabian Penin-sula and in North Africa, three ALS2 mutations were identified. All ALS2 mutations give rise to C-terminally truncated alsin proteins due to frameshifts caused by nucleotide deletions (Fig. 1 ). All affected individuals harbor a homozygous alsin mutation. The Tunisian mutation (138delA), affecting both alsin LF and SF, causes juvenile-onset ALS, a severe MND with progressive disturbance of both upper and lower motor neurons, in the first or second decade of life. In contrast, both Kuwaiti (1425-1426delAG) and Saudi (1867-1868delCT) mutants affect alsin LF exclusively, and patients exhibit primary lateral sclerosis phenotype with impairment of upper motor neurons. Recently, it is reported that other alsin truncations also lead to another MND, infantile onset ascending hereditary spastic paralysis (17) . It has been hypothesized from these observations that loss of some functions of alsin results in MND.
In this study, we examined functions of alsin by using alsin LF, alsin SF, alsin native mutants (alsin-Tunisian, alsin-Kuwaiti, and alsin-Saudi), and some other artificial alsin mutants (Fig. 1) . First, we found that alsin LF, but not alsin SF, protected NSC34 cells, the model cell line for motor neurons (18) , from SOD1 mutant-induced neurotoxicity. The RhoGEF domain is involved in alsin LF-mediated neuroprotection. Second, we found that alsin LF physically binds to SOD1 mutants. The site responsible for alsin LF binding to SOD1 mutants is located in the alsin RhoGEF domain. This novel interaction, both functional and physical, between independently identified ALS-causative genes would provide an essential clue to elucidate the precise molecular mechanisms underlying ALS and other MNDs.
EXPERIMENTAL PROCEDURES
Antibodies-The mouse monoclonal anti-FLAG antibody (M2) and horseradish peroxidase (HRP)-conjugated anti-FLAG antibody were purchased from Sigma. The mouse monoclonal anti-Myc antibody, the mouse monoclonal anti-Xpress antibody, and HRP-conjugated antiHisG antibody which recognizes His 6 Gly tag were purchased from Invitrogen. The mouse monoclonal anti-human SOD1 antibody was purchased from MBL International Corp. (Nagoya, Japan). The goat polyclonal anti-SOD1 antibody recognizing both mouse and human SOD1, the rabbit polyclonal anti-His 6 antibody, and the HRP-conjugated donkey anti-goat IgG antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The HRP-conjugated goat polyclonal anti-mouse IgG antibody and the HRP-conjugated goat polyclonal antirabbit antibody were purchased from Bio-Rad.
Cell Culture, Transfection, and Cell Death Assay-NSC34 cells were provided by Dr. Neil Cashman of the University of Toronto and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics. NSC34 cell is a hybrid cell line of motor neurons, derived from embryonic mouse spinal cord cells and mouse neuroblastoma (18, 19) . These cells are one of the best models for primary cultured motor neurons exhibiting a number of characteristics for primary cultured motor neurons, including generation of action potential, acetylcholine synthesis, storage, and release.
For transient transfection of ALS2 and other genes, NSC34 cells were seeded at 7 ϫ 10 4 cells/well in a 6-well plate, cultured in DMEM plus 10% FBS for 12-16 h, and then transfected with ALS2 or other genes by lipofection (DNA:LipofectAMINE:PLUS Reagent ϭ 1 g, 2 l, 4 l) in the absence of serum for 3 h. LipofectAMINE and PLUS Reagent were purchased from Invitrogen. The transfected NSC34 cells were incubated with DMEM plus 10% FBS. Twenty-four hours after the onset of transfection, the culture medium was changed to DMEM plus N2 supplement (Invitrogen), and cells were incubated for an additional 48 h. In specified experiments, cells were cultured in the presence of 2 M MG132 (Calbiochem) for 24 h just before the harvest. Seventy-two hours after transfection, cell mortality was measured by the trypan blue exclusion assay performed as follows. Cells were suspended by pipetting gently, and 50 l of 0.4% trypan blue solution (Sigma) was mixed with 200 l of the cell suspension (final concentration 0.08%) at room temperature. Stained cells were counted within 3 min after the mixture with trypan blue solution. The mortality of cells was then determined as a percentage of trypan blue-stained cells in total cells. Cell mortality assessed by this method thus represents the population of dead cells in total cells, including both adhesive and floating cells at the termination of experiments. It has been established by our reported experiments that our cell mortality assay by the trypan blue exclusion test gives precisely reciprocal results of WST-8 assay, the most established cell viability assay (20) . WST-8 assay was performed with 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8), using Cell Counting kit-8 (Wako Pure Chemicals Industries, Tokyo, Japan). After transfection, cells were incubated for 72 h and then suspended in phosphate-buffered saline, and 1/10 volume (100 l) of the cell suspension was incubated with 10 l of WST-8 solution in a 96-well plate for 2 h at 37°C. Absorbance of the samples at 450 nm wavelength was measured by Wallac 1420 ARVOsx Multi Label Counter.
DNA Construction-Full-length alsin SF cDNA was obtained from human heart cDNA (BioChain) by PCR using a sense primer (ACTAG-TACCATGGACCAAAGAAGAGAAGCTC) and an antisense primer (GCGGCCGCGCTACCAAGCCTTACCCCTTTTAAAG). Full-length alsin LF cDNA was generated by fusing three DNA fragments. We used the alsin SF cDNA as the first fragment. The second fragment, corresponding to the region from the first EcoRI site to the NheI site of alsin LF, was obtained from human thalamus cDNA (BioChain) by PCR using a sense primer (GCTTCCATAGTGGAGCAGTGACAGAC) and an FIG. 1. Schematic illustration of domains and motifs identified in the normal and mutant alsin. There are three putative GTPase regulator domains in alsin LF. Regulator of chromosome condensation 1 (RCC1) is known as a GEF for the nuclear GTP-binding protein Ran. The middle region composed of the DH and PH domains is known to have a common structure with GEFs for the small G protein Rho. The VPS9 domain is seen in some GEFs including Vps9, Rabex-5, and RIN, known as mediators of endocytosis and vesicle trafficking. Membrane occupation and recognition nexus (MORN) motifs, implicated in binding to plasma membrane, are observed in the region between the RhoGEF domain and the VPS9 domain. By alternative splicing, alsin SF has a unique sequence consisting of 25 amino acids (starting from the 372nd residue). Similarly, the Tunisian, the Kuwaiti, and the Saudi mutants have unique residues due to frameshifts caused by nucleotide deletions. Alsin- contains the N-terminal 756 amino acids. Alsin- contains the N-terminal 1048 amino acids just before the first MORN motif. Alsin-(1-1048)-⌬(86 -371) fragment was constructed by deleting the region spanning from the 86th to 371st amino acid from alsin-(1-1048). Alsin DH-PH contains the complete RhoGEF domain. Alsin DH or alsin PH contains only the DH domain or the PH domain of the RhoGEF. See the text for details.
antisense primer (GCGGCCGCCTCAATGAGGCTCCATGCTGACC). The third fragment, corresponding to the region from the NheI site to the last amino acid, was obtained from human heart cDNA by PCR using a sense primer (GCCACTACAGGAAGACCCAG) and an antisense primer (GCGGCCGCGTTAAGCTTCTCACGCTGAATCTGG). The structure of the reconstituted alsin LF cDNA was examined by sequencing. Alsin cDNAs were subcloned into the pEF1/Myc-His plasmid (Invitrogen). Mouse alsin cDNA was obtained by RT-PCR. Total RNA extracted from murine cerebrum using ISOGEN kit (Nippon Gene) was used for RT-PCR with a High Fidelity RNA PCR kit (Takara, Shiga, Japan). Before generating the full-length mouse alsin cDNA, we amplified two cDNA fragments by RT-PCR. The first fragment, spanning from the start codon to the EcoRV site, was obtained by RT-PCR using a sense primer (ACTAGTACCATGGACTCAAAGAAGAAAA-GCTCAAC) and an antisense primer (TTGGCACACATCATCCTGCC). The second fragment, spanning from the EcoRV site to the last amino acid, was obtained by RT-PCR using a sense primer (GCATGTTCATT-GGCCAGTGG) and an antisense primer (GCGGCCGCGTTAAGCT-TCTCCCGCTGAATC). The reconstituted mouse ALS2 gene was subcloned into the pEF1/Myc-His plasmid. We used alsin LF as the template for cDNA synthesis of the alsin Tunisian mutant and performed site-directed mutagenesis to delete a nucleotide (138delA) with a sense primer (GTTTTGCAGGCGCCCTCGGAGGCGGCCGCATGGA-GTTCTTCTGACTGAAG) and an antisense primer (CTTCAGTCAGA-AGAACTCCATGCGGCCGCCTCCGAGGGCGCCTGCAAAAC). We used alsin LF as the template for cDNA synthesis of the alsin-Kuwaiti mutant and performed site-directed mutagenesis to delete two nucleotides (1425-1426delAG) with a sense primer (GGATATCAGAGAAGA-AGAAACAGGGAGGCAGTCGAAG) and an antisense primer (CTTCG-ACTGCCTCCCTGTTTCTTCTTCTCTGATATCC). We used alsin LF as the template for the alsin-Saudi mutant and performed site-directed mutagenesis to delete two nucleotides (1867-1868delCT) using a sense primer (GCTGCAGGCAGGGATTATTCCGTTTTTAGTGGATACAG-AAG) and an antisense primer (CTTCTGTATCCACTAAAAACGGAA-TAATCCCTGCCTGCAGC). The alsin-Tunisian mutant cDNA, the alsin-Kuwaiti mutant cDNA, and the alsin-Saudi mutant cDNA were subcloned into pEF1/Myc-His vector. cDNA for alsin-(1-756) was derived from alsin LF. For synthesis of alsin-(1-1048) cDNA, we performed PCR with a sense primer (ACTAGTACCATGGACCAAAGA-AGAGAAGCTC) and an antisense primer (GCGGCCGCGGTGGCATC-CTTTAGGCGAGG), and we subcloned its product into pEF1/Myc-His vector. For cDNA synthesis of alsin DH-PH, alsin DH, and alsin PH, we used alsin LF as the template. We performed PCR with a sense primer (GGGTACCATGCTCCACGAGTTAGCTACTAC) for alsin DH-PH and alsin DH, or another sense primer (CGGGATCCGGGAGGTTTTCCGT-GAATTGG) for alsin PH, together with an antisense primer (GGAAT-TCAGCAAGACACTCATAACAAGAACTGG) for alsin DH-PH, and alsin PH or another antisense primer (GGAATTCAGCCTGATCTACG-GCTTGGC) for alsin DH. Alsin DH-PH, alsin DH, and alsin PH were subcloned into the pEF4/His vector (Invitrogen). Alsin cDNA fragments with amino acids deletion from 86th to 371st were constructed as follows. In order to delete the region common to alsin LF and SF, we performed site-directed mutagenesis to create another XbaI site using a sense primer (GCATGGTGAAAAGCCAATGCCATCTAGAACCTCTTT-TAGAAGAAGCAATTCC) and an antisense primer (GGAATTGCTTC-TTCTAAAAGAGGTTCTAGATGGCATTGGCTTTTCACCATGC). After digestion with XbaI, the plasmids were self-ligated. cDNAs encoding wtSOD1, A4T-SOD1, G85R-SOD1, and G93R-SOD1, kindly provided by Dr. Shoji Tsuji of the University of Tokyo, were subcloned into pFLAG-CMV-5a (pFLAG; Eastman Kodak Co.).
Immunoprecipitation-NSC34 cells were seeded on a 6-well plate and transiently co-transfected with pEF1/Myc-His-alsin LF, alsin SF, or one of alsin mutants together with pFLAG-wtSOD1 or pFLAG-SOD1 mutants. After 48 h of incubation, cells were harvested and solubilized with lysis buffer (20 mM HEPES/NaOH (pH 7.4), 1 mM dithiothreitol, 1 mM EDTA, 150 mM NaCl, 0.5% Triton X-100). The cell lysates were immunoprecipitated using monoclonal anti-FLAG M2-agarose affinity gel (Sigma) for 8 h at 4°C, washed three times with the lysis buffer, and finally eluted by boiling in 4% SDS sample buffer for 5 min. Only when vectors encoding SOD1 mutants without the FLAG tag were used for co-transfection, the immunoprecipitation was performed with the goat polyclonal anti-SOD1 antibody (Santa Cruz Biotechnology) and protein G-Sepharose beads (Amersham Biosciences).
Immunoblotting-Cell lysates (20 g/lane) or immunoprecipitates were subjected to SDS-PAGE, and separated proteins were transferred onto polyvinylidene difluoride membranes. For detection of various alsin derivatives, membranes were probed with the primary anti-Myc monoclonal antibody (1:2000, Invitrogen) and the secondary antibody, HRP-conjugated anti-mouse IgG antibody (1:5000, Bio-Rad), followed by visualization of the immunoreactive bands by ECL (Amersham Biosciences). Alsin DH-PH and alsin DH were detected by the anti-Xpress monoclonal antibody (1:1000, Invitrogen) and the secondary antibody, HRP-conjugated anti-mouse IgG antibody (1:5000, Bio-Rad). Immunoblotting of various SOD1 constructs was similarly performed with the primary mouse monoclonal anti-SOD1 antibody (MBL International Corp.) and the secondary antibody, HRP-conjugated anti-mouse IgG antibody (Bio-Rad). Alsin and its derivatives were probed with the anti-His 6 antibody or the HRP-conjugated anti-HisG antibody, and SOD1 was probed with the anti-SOD1 polyclonal antibody or the HRPconjugated anti-FLAG antibody in some experiments. Immunoblotting of presenilin1 (PS1), presenilin2 (PS2), and amyloid-␤ precurser protein (A␤PP) was performed as described previously (4, 21, 22) . For coimmunoprecipitation experiments of alsin LF, derivatives of alsin LF and SOD1, we chose the antibody for immunoblotting to minimize the background staining derived from the immunoglobulin. Consequently, the antibody used for immunoblotting of inputs was sometimes different from the one used for immunoblotting of co-immunoprecipitates.
Immunostaining-NSC34 cells were seeded on a 6-well plate and transiently transfected with indicated constructs. After 48 h of incubation, the cells were fixed with 4% paraformaldehyde and labeled with anti-His 6 antibody. Secondary antibody was rhodamine-swine anti-rabbit IgG antibody (Dako). Fluorescence signals were detected with a laser scanning confocal microscope LSM (Carl Zeiss, Germany).
RESULTS

Expression of SOD1 Mutants Induces Death of Motor Neuronal Cells, NSC34
Cells-Multiple groups have reported that overexpression of SOD1 mutants induces cell death for neuronal cell lines and primary neurons (3, 23) . In agreement, we have observed that mutant SOD1 expression causes cell death in F11 neurohybrid cells (hybrid cells of rat primary dorsal root ganglion neurons and mouse neuroblastoma cells) (4). These findings suggest that SOD1 mutants have the potential to induce cell death for at least certain types of neuronal cells. To confirm that neurotoxicity induced by overexpression of SOD1 mutants involves the motoneuronal cells, we performed a cell death assay using NSC34 cells as an established model for motor neurons. NSC34 is a hybrid cell line generated by fusing embryonic mouse spinal cord cells, in which motor neurons are highly enriched with mouse neuroblastoma cells (18, 19) . It is used worldwide as a model for primary cultured motor neurons with a number of motoneuronal characteristics, including occurrence of action potentials as well as synthesis, storage, and release of acetylcholine. We transiently transfected NSC34 cells with wild-type SOD1 (wtSOD1) or SOD1 mutants (A4T-, G85R-, and G93R-SOD1). Seventy-two hours after the transfection, the trypan blue exclusion assay was performed to calculate cell mortality ( Fig. 2A) . Transient expression of A4T-SOD1 mutant resulted in ϳ50% decrease in viable cells. Similar results were obtained from expression of G85R-SOD1 and G93R-SOD1. In contrast, expression of wtSOD1 did not induce cell death in NSC34 cells.
Alsin LF Protects Neuronal Cells from Toxicity by SOD1 Mutants-All known mutants of alsin in MNDs are C-terminally truncated due to nucleotide frameshifts (alsin LF is selectively truncated in most cases). Considering that this type of MND is recessively inherited, truncation-specific loss of function of alsin is assumed to contribute to selective disappearance of motor neurons in ALS. On the contrary, almost all SOD1 mutants have amino acid substitutions, and furthermore, some mutants maintain their original function as a scavenger of free radicals (24) . They are therefore considered to cause ALS by gain of toxic function. Based on these assumptions, we further hypothesized that alsin plays an essential role in survival of motor neurons and that overexpression of alsin, especially alsin LF, may antagonize and suppress neurotoxicity induced by SOD1 mutants.
When NSC34 cells were transfected with A4T-SOD1 alone, cell mortality was drastically increased (Fig. 2B) . When these cells were co-transfected with A4T-SOD1 and alsin LF, cell mortality was kept almost completely to the mortality level of cells transfected with the pEF-BOS backbone vector alone. Similar results were obtained from cell death assays using G85R-SOD1 and G93R-SOD1 (Fig. 2B) , and these results indicate that alsin protected cells from SOD1 mutant-induced neurotoxicity. Note that alsin LF did not inhibit expression of SOD1 mutants (Fig. 2B, lower panel) . The murine alsin ortholog, termed mouse alsin, has neuroprotective activity similar to alsin LF (Fig. 2C) . In contrast, alsin SF did not have neuroprotective activity. The MND mutants of alsin, alsinKuwaiti and alsin-Saudi, lost neuroprotective activity against SOD1 mutant-induced neurotoxicity (Fig. 2D) .
The RhoGEF Domain Is Essential for Alsin-mediated Neuroprotection-To specify the domain for alsin-mediated neuroprotection, we constructed two alsin deletion mutants, alsin-(1-756) (the N-terminal 756 amino acids residues of alsin) and alsin-(1-1048) (Fig. 1) , and we then examined their rescue function. Alsin-(1-756) could not protect neuronal cells from A4T-SOD1-induced neurotoxicity, whereas alsin-(1-1048), which contains the entire RhoGEF domain, elicited full neuroprotective activity (Fig. 2D) . The RhoGEF domain was therefore considered to be essential for alsin LF to exert neuroprotection from SOD1 mutant-induced neurotoxicity.
The alsin RhoGEF domain consists of Dbl homology (DH) domain and pleckstrin homology (PH) domain arranged in tandem (Fig. 1) . We constructed pEF4/His-alsin DH-PH (pEF4 plasmid encoding N-terminally His 6 Gly-Xpress-tagged alsin DH-PH), pEF4/His-alsin-DH, and pEF4/His-alsin-PH to examine their rescue activity (Fig. 3, A-D) . Unfortunately, however, protein expression of alsin PH was very low in the usual culture condition (data not shown). It was detectable restrictedly in the presence of MG132, a proteasome inhibitor. We therefore needed to perform a separate experiment using MG132 to test the effect of alsin PH on cell death. As indicated in Fig. 3B , alsin DH-PH, but not alsin DH, has as strong neuroprotective activity as alsin-(1-1048) against A4T-SOD1-induced toxicity in the usual culture condition without MG132 (Fig. 3, A and B) . In the presence of MG132, alsin DH-PH, but not alsin DH nor alsin PH, has significant neuroprotective activity (Fig. 3, C and  D) , confirming that alsin LF needs the full-length RhoGEF domain to exert its neuroprotection. Note that MG132 is somewhat toxic to cells, and treatment of 2 M MG132 increased basal death rate (Fig. 3C) .
Meanwhile, it should be noted that when SOD1 mutants were co-transfected with alsin DH-PH, their expression levels decreased (Fig. 3, A-C) . To eliminate the possibility that neuroprotection by alsin DH-PH was due to inhibition of SOD1 expression, we examined the dose-dependent toxicity induced by SOD1 mutants in detail (Fig. 3, E and F) . For that purpose, NSC34 cells were transfected with stepwise increased amounts of the A4T-SOD1 plasmids. To keep the total amount of transfected plasmids constant, we added appropriate amounts of the backbone vector for each transfection. Expression of A4T-SOD1 induced neurotoxicity in a dose-dependent manner when less than 0.3 g of A4T-SOD1 plasmids were transfected. A4T-SOD1-induced neurotoxicity reached a plateau when more than 0.3 g of A4T-SOD1 plasmids were transfected. Although co-transfection with alsin DH-PH reduced the A4T-SOD1 expression level approximately by half, the expression level was still high enough to cause massive neuronal death (Fig. 3E,  lower panel) (27) . We also observed that all these insults cause cell death in NSC34 motoneuronal cells. Notably, alsin LF had no protective activity against neuronal cell death induced by each of these insults (Fig. 4, A and B) . These results support the notion that alsin has neuroprotective activity that is specifically effective against ALS-related insults.
Physical Interaction between Alsin and SOD1-Alsin has neuroprotective activity specifically against the ALS gene (SOD1 mutants) but not against the FAD genes or the FPD gene. A simple interpretation for this functional specificity is that alsin modifies activity of SOD1 mutants by directly or almost directly interacting with SOD1 mutants. To examine this possibility, we performed co-immunoprecipitation experiments using the lysates of the NSC34 cells co-transfected with Myc-His 6 -tagged alsin LF or SF together with wtSOD1-FLAG or mutant SOD1-FLAG. Precipitates containing wtSOD1-FLAG or mutant SOD1-FLAG immunoprecipitated with the antibody to FLAG were fractionated by SDS-PAGE and then immunoblotted with the antibody to His 6 . Both alsin LF and alsin SF were detected in the precipitates containing SOD1 mutants (A4T-, G85R-, and G93R-SOD1) (Fig. 5A) . However, alsin LF did not bind to wtSOD1, whereas alsin SF did so under the same condition (Fig. 5A) , indicating that alsin SF binds to both wtSOD1 and SOD mutants, whereas alsin LF specifically binds to SOD mutants.
Next, we examined whether the known naturally occurring alsin mutants and an artificially generated alsin mutant, alsin-(1-1048), which is deficient in the C-terminal region consisting of 609 amino acids, bind to wtSOD1 or SOD1 mutants (Fig. 5B) . All tested alsin mutants, except the Tunisian mutant, were able to bind to SOD1 mutants. In contrast to wild-type alsin LF, the alsin-Kuwaiti mutant, the Saudi mutant, and alsin-(1-1048) bound to wtSOD1 (Fig. 5C ). The straightforward interpretation for these observations is that alsin SF, contained in all these alsin mutants except the Tunisian mutant, is responsible for interaction with both wtSOD1 and SOD1 mutants, and the C-terminal region of alsin is involved in preventing alsin LF from binding to wtSOD1.
To further explain why alsin LF, which contains alsin SF, binds to SOD1 mutants but not to wtSOD1, we hypothesized that in alsin LF the alsin SF-corresponding region is masked by some other regions containing the C-terminal region and therefore is inaccessible to SOD1. Instead, there is another region, other than the alsin SF-corresponding region in alsin LF, that is responsible for the specific binding to SOD1 mutants. To verify this hypothesis, we deleted a region spanning from the 86th to the 371st amino acids, which covers the nearly full region of alsin SF, from alsin-(1-1048) to make an alsin mutant named alsin-(1-1048)⌬(86-371). Alsin-(1-1048)⌬(86-371) binds to SOD1 mutants but not to wtSOD1 (Fig. 5D) , indicating that there is in fact another region other than the alsin SF-corresponding region that is involved in the specific binding to SOD1 mutants. Simultaneously, this finding supports the idea that the alsin SFcorresponding region is masked by some other regions containing the C-terminal 609 amino acids region of alsin LF. Furthermore, we concluded that the binding region other than the alsin SF-corresponding region is located in alsin DH-PH (the alsin RhoGEF domain) because alsin DH-PH bound to SOD1 mutants but not to wtSOD1 (Fig. 5E ).
To specify further the subregion of alsin DH-PH responsible for binding to SOD1 mutants, we co-expressed alsin DH-PH, alsin DH, alsin PH, or alsin-Tunisian mutant together with the   FIG. 3 . The entire alsin RhoGEF domain is necessary for alsin-mediated neuroprotection against toxicity by SOD1 mutant. A and B, the alsin RhoGEF domain is responsible for alsin-mediated neuroprotection against toxicity by SOD1 mutant. NSC34 cells were co-transfected with the pEF-BOS vector (vector) or A4T-SOD1 together with the pEF1/Myc-His vector, alsin-(1-756) (756), alsin-(1-1048) (1048), the pEF4/His vector, pEF4/His-alsin DH-PH (DH-PH), or pEF4/His-alsin DH (DH). Cell mortality was determined by the trypan blue exclusion test (A) and WST-8 assay (B). Immunoblot analysis was performed with the anti-SOD1 antibody, the anti-Myc antibody, and the anti-Xpress antibody (lower panels). C and D, the alsin DH domain or the alsin PH domain does not elicit neuroprotection against toxicity by SOD1 mutants. NSC34 cells were co-transfected with the pEF-BOS vector (vector) or A4T-SOD1 together with the pEF4/His vector, pEF4/His-alsin DH-PH (DH-PH), pEF4/His-alsin DH (DH), or pEF4/His-alsin PH (PH). They were cultured in the presence of 2 M MG132 for 24 h before the harvest. Cell mortality and cell viability was determined by the trypan blue exclusion test (C) and the WST8 assay (D). Immunoblot analysis was performed with the anti-SOD1 antibody and the anti-HisG antibody (lower panels). E and F, expression of SOD1 mutants induces neurotoxicity in a dose-dependent fashion. NSC34 cells were co-transfected with the pEF-BOS vector (pEF-BOS vec) or pEF-BOS-A4T-SOD1 (A4T-SOD1) together with pEF4/His vector or pEF4/His-alsin DH-PH (DH-PH). The total amount of pEF-BOS-related plasmids was 0.5 g/well. The amounts of A4T-SOD1 plasmids were increased stepwise by 0.1 g/well. Cell mortality was determined by the trypan blue exclusion assay (E) and the WST-8 assay (F) using the same samples. Immunoblot analysis was performed with the anti-SOD1 antibody and the anti-Xpress antibody.
G93R-SOD1-FLAG mutant in the presence of MG132, and we performed co-immunoprecipitation experiments (Fig. 5, F and  G) . Alsin DH-PH, alsin DH, and alsin PH, but not alsin-Tunisian mutant, were co-immunoprecipitated with the SOD1 mutant. Combining this finding and the finding obtained by the death assays shown above (Fig. 3, C and D) , we concluded that although alsin DH alone or alsin PH alone binds to SOD1 mutants, neither of them has neuroprotective function, and the whole RhoGEF domain is necessary for alsin LF-mediated inhibition of neurotoxicity by SOD1 mutants.
Note that in these co-immunoprecipitation experiments, the amounts of immunoprecipitated SOD1 mutants were usually quite small. We speculate that the low immunoprecipitability of SOD1 is linked to a tendency of SOD1 to aggregate in the cells.
Deletion of Alsin-(86 -371) from Alsin Does Not Affect Alsin LF Rescue
Function-So far, we demonstrated that alsin-(86 -371) is essential for alsin mutants containing the alsin SFcorresponding region to bind to both wtSOD1 and SOD1 mutants. In addition, the alsin RhoGEF domain of alsin LF, containing another binding region, binds to SOD1 mutants but not to wtSOD1. To examine whether the binding region in the alsin SF-corresponding region is necessary for alsin LF to exert its neuroprotective activity, we performed the cell death assay with alsin LF⌬- (86 -371) and alsin-(1-1048)⌬(86 -371) . Both alsin LF⌬-(86 -371) and alsin-(1-1048)⌬(86 -371) constructs are protective, but they are less protective than is the wild type (Fig. 5H) . This result indicates that the binding region in alsin SF is not essential for alsin LF to suppress SOD1 neurotoxicity, although it exerts some positive influence on alsin LF-induced suppression of SOD neurotoxicity. This is in agreement with the finding that alsin SF does not have neuroprotective activity.
Subcellular Co-localization of Alsin LF and a SOD1 Mutant-To confirm further the interaction between alsin and SOD1 in vivo, subcellular localization of alsin LF and G85R-SOD1 was examined by immunocytochemical analysis using confocal microscopy (Fig. 6) . When NSC34 cells transfected with alsin LF or SF were stained with anti-His 6 antibody (alsins were tagged with His 6 ) and rhodamine-conjugated secondary antibody, both were detected to be localized in the cytoplasm (Fig. 6) . No signals were observed when untransfected cells were stained with anti-His 6 antibody (data not shown). When NSC34 cells were transfected with G85R-SOD1-EGFP, fluorescent signals likely indicating some aggregates of SOD1 were observed in the cytoplasm, whereas no signals were detected in untransfected cells.
To examine whether aggregates of SOD1 are co-localized with alsin LF or SF, NSC34 cells were co-transfected with alsin LF or alsin SF (red) and G85R-SOD1-EGFP (green), and stained with anti-His 6 antibody. Both alsin LF and SF were co-localized in the G85R-SOD1-EGFP aggregates, as revealed by yellow staining in the merge panels of Fig. 6 . These findings may support the notion that alsin LF and SF interact with SOD1 mutants in vivo, although we could not exclude the possibility that alsin LF and SF seemed to have co-localized with SOD1 mutants by adventitious shift of overexpressed alsin SF/LF or SOD1 mutants.
Alsin LF Does Not Affect Ubiquitination of Mutant SOD1-One of the pathological hallmarks of ALS is the presence of the inclusion bodies, which consist of aggregated, ubiquitinated proteins, in surviving motor neurons in both sporadic and familial ALS (28) . It has been reported that when wtSOD1 or mutant SOD1 is transiently overexpressed with ubiquitin, only mutant SOD1 is co-immunoprecipitated with poly-ubiquitin (29) . In addition, a novel centrosomal ring finger protein, Dorfin (double ring-finger protein), which exhibits ubiquitin-protein isopeptide ligase activity, ubiquitinates mutant SOD1 and reduces mutant SOD1 neurotoxicity (5, 23) . These data imply that ubiquitination of mutant SOD1 leads to the attenuation of SOD1 mutant-induced neurotoxicity by enhancing degradation of SOD1 mutants. We therefore examined whether alsin LF rescues neuronal cells in a ubiquitin proteasome-dependent manner. For this purpose, we used not only NSC34 cells but also F11 cells. After NSC34 cells or F11 cells were co-transfected with alsin LF, G93R-SOD1-FLAG and HA-tagged ubiquitin (HA-ubiquitin), we immunoprecipitated G93R-SOD1-FLAG using the anti-FLAG antibody, followed by immunoblotting with the anti-HA antibody. G93R-SOD1-FLAG was highly ubiquitinated as reported (Fig. 7) , whereas its ubiquitinated level was not altered in the presence of alsin LF. Alsin LF-mediated neuroprotection should therefore be independent from the ubiquitin proteasome-dependent mechanism. DISCUSSION Here we found that alsin LF, but not alsin SF, protects NSC34 cells, the model cell line for motor neurons (18) , from SOD1 mutant-induced neurotoxicity. In addition, we found that alsin LF physically binds to SOD1 mutants. To obtain these results, we used transient transfection techniques. We did not use stable cell lines that are engineered to express SOD1 mutants by a certain induction condition, because they always become partially resistant to SOD1 mutant during selection with antibiotics. It could be speculated that leaky expression of SOD1 mutant confers relative resistance to toxicity by SOD1 mutants.
Among three putative GEF domains of alsin LF (Fig. 1) , the VPS9 domain of alsin LF has a function as a GEF for the small GTPase Rab5 (16) . In contrast, function of the other two GEF domains has been unknown. Here we have demonstrated that the RhoGEF domain of alsin LF is essential not only for binding to SOD1 mutants but also for alsin-mediated neuroprotection. The RhoGEF domain consists of two subdomains (Fig. 1) . The PH domain of the RhoGEFs is necessary for transforming activity of the RhoGEFs (30) . It also has been shown that the PH domain mediates translocation of RhoGEF from cytoplasm to plasma membrane (31, 32) . They suggest that the PH domain supports the guanine nucleotide exchanging activity of the DH domain and that the PH domain is therefore essential for RhoGEF to exert its function in vivo. Deletion of the PH domain or the DH domain from the RhoGEF domain of alsin LF completely abolishes its neuroprotective activity, suggesting that the whole Rho-GEF domain is essential for alsin-mediated neuroprotection. were co-transfected with pEF-BOS-A4T-SOD1 (A4T-SOD1) together with pEF1/Myc-His-alsin SF (SF), pEF1/Myc-His-alsin-Kuwaiti (Kuwaiti), or pEF1/Myc-His-alsin-Saudi (Saudi). Immunoprecipitation was performed with the anti-SOD1 antibody. Immunoblot analysis was performed with the anti-Myc antibody or the anti-SOD1 antibody. C, wtSOD1 interacts with alsin mutants, but not with alsin LF. NSC34 cells were co-transfected with pFLAG-wtSOD1 (wtSOD1-FLAG) together with pEF1/Myc-His-alsin-Kuwaiti (Kuwaiti), alsin-Saudi (Saudi), alsin-(1-1048) (1048), or alsin LF (LF). Immunoblot analysis of input lysates was performed with the anti-Myc antibody or the anti-SOD1 antibody (left 4 lanes). Immunoprecipitation was performed with anti-FLAG M2 beads, and precipitates were immunoblotted with the anti-His 6 antibody or the anti-SOD1 antibody (right 4 lanes). D, deletion of alsin-(86 -371) prohibits alsin-(1-1048) from binding to wtSOD1. NSC34 cells were co-transfected with the pFLAG empty vector (vec), pFLAG-wtSOD1 (wt), or indicated FLAG-tagged SOD1 mutants together with pEF1/Myc-His-alsin-(1-1048)-⌬(86 -371) (1048⌬) or pEF1/Myc-His-alsin-(1-1048) (1048). Immunoblot analysis of input lysates was performed with the anti-Myc antibody or the anti-SOD1 antibody (upper panels). Immunoprecipitation was performed with the anti-FLAG M2 beads, and precipitates were immunoblotted with the anti-His 6 antibody or the anti-SOD1 antibody (lower panels). E, SOD1 mutants bind to the alsin DH-PH domain. NSC34 cells were co-transfected with the pFLAG vector (vec), pFLAG-wtSOD1 (wt), or the indicated FLAG-tagged SOD1 mutants together with pEF4/His-alsin DH-PH. Immunoblot analysis of input lysates was performed with the anti-Xpress antibody and the anti-SOD1 antibody (left 5 lanes). Immunoprecipitation was performed with anti-FLAG M2 beads, and precipitates were immunoblotted with the anti-His 6 antibody or the anti-SOD1 antibody (right 5 lanes). F and G, G93R-SOD1 binds to both the alsin DH domain and the alsin PH domain. NSC34 cells were co-transfected with the FLAG-tagged G93R-SOD1 together with pEF4/His-alsin DH-PH, pEF4/His-alsin DH, pEF4/His-alsin PH, or pEF1/Myc-His-alsin-Tunisian. They were cultured in the presence of 2 M MG132 for 24 h before the harvest. Immunoprecipitation was performed with anti-FLAG M2 beads, and precipitates were immunoblotted with the HRP-conjugated anti-HisG antibody (F), anti-His 6 antibody (G), or the HRP-conjugated anti-FLAG antibody. The most outstanding characteristic of alsin LF-mediated neuroprotection is that it is effective only for SOD1 mutants but not for other neurodegenerative insults such as expression of M146L-PS1, N141I-PS2, V642I-A␤PP, K595N/M596L-A␤PP, and A53T-␣-synuclein, suggesting that alsin LF suppresses SOD1 mutant-induced neurotoxicity by directly or almost directly binding to SOD1 mutants. Consistent with this notion, it is indicated in this study that alsin LF is co-immunoprecipitated with SOD1 mutant. This interaction is never considered to be an artifact during experimental procedures because (i) alsin LF does not interact with wtSOD1 under the same condition; (ii) the RhoGEF domain has been identified as the site responsible for interaction with SOD1 mutants; (iii) alsin LF seems to be co-localized with aggregates of SOD1 mutants.
A straightforward hypothesis regarding function of alsin LF in vivo is that alsin LF is located upstream of SOD1 mutant, and it monitors and compromises neurotoxic effects generated by SOD1 mutants, putatively through direct interaction with SOD1 mutants. Another possibility is that alsin LF is functionally located downstream of SOD1. In this assumption, alsin LF works as a kind of prosurvival factor by activating unidentified small GTPases linked to cell survival signals, and SOD1 mutants impair its function. We need further investigation to determine which hypothesis is the case. This is the first report showing that two independent ALSrelated genes functionally and physically interact with each other. It still remains unclear whether impairment of this neuroprotective activity of alsin is truly linked to the onset of ALS and MND. The fact that the two ALS2 mutants, alsinKuwaiti and alsin-Saudi, are defective in neuroprotective activity leads to the speculation that a deficit of this neuroprotective activity would result in MND. It should be noted, however, that an alsin mutant lacking 1 bp in the VPS9 domain has been reported to cause Pakistani infantile-onset autosomal recessive complicated hereditary spastic paraplegia (33), although this mutant is expected to harbor the complete neuroprotective activity against SOD1 mutant-induced neurotoxicity. Otomo et al. (16) found that alsin plays a role in endosomal dynamics through the VPS9 domain of alsin. Here we find that alsin plays a role in neuroprotection from SOD1 mutant-induced toxicity. Neuroprotective activity of alsin shown here is currently not directly linked to endosomal dynamics, suggesting that alsin has multiple independent activities. Multiple functional defects of alsin, not a single defect, may lead to the onset of MND with a variety of neuronal abnormalities. It will be thus quite important to understand the precise function of alsin as an MND-related gene. For that purpose, this study provides an essential clue.
